false 0001771706 A1 0001771706 2025-03-06 2025-03-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 6, 2025

 

VIREO GROWTH INC.

(Exact name of registrant as specified in its charter)

 

British Columbia

(State or other jurisdiction of Incorporation)

 

000-56225   82-3835655
(Commission File Number)   (IRS Employer Identification No.)
     

207 South 9th Street

Minneapolis, Minnesota

  55402
(Address of principal executive offices)   (Zip Code)

 

(612) 999-1606

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
N/A N/A N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

Item 5.02.         Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

As reported on the Form 8-K for Vireo Growth Inc. (the “Company”) filed December 23, 2024, the Company entered into employment agreements dated December 17, 2024 with each of its Chief Executive Officer, John Mazarakis, and its Chief Financial Officer, Tyson Macdonald. On March 6, 2025, the Company and each of Mr. Mazarakis and Mr. Macdonald entered into amendments to their original employment agreements.

 

Mazarakis Amendment to Employment Agreement

 

Under Mr. Mazarakis’s employment agreement dated December 17, 2024 (the “Original Mazarakis Employment Agreement”), Mr. Mazarakis was to be issued 19,000,000 Restricted Stock Units settled in subordinate voting shares of the Company (the “Time-Vested RSUs”). The Time-Vested RSUs were to become 50% vested upon the first anniversary of the Effective Date (as defined under the Original Mazarakis Employment Agreement) and the balance was to vest at the rate of 12.5% every three months thereafter until fully vested provided that Mr. Mazarakis remained employed by the Company or an affiliate as of each applicable vesting date. Pursuant to Amendment No. 1 to the Original Mazarakis Employment Agreement dated March 6, 2025 (“Mazarakis Amendment No. 1”), Mr. Mazarakis will now receive 19,000,000 Time-Vested RSUs that will become 30% vested upon the first anniversary of the Effective Date. An additional 35% shall become vested when the 30-day weighted average price (“VWAP”) of the Company’s shares exceeds $0.85 (adjusted for dividends and stock splits) at any time on or after the second anniversary of the Effective Date and during the term of the Original Mazarakis Employment Agreement. Any unvested shares shall become vested when the VWAP exceeds $1.05 (adjusted for dividends and stock splits) at any time on or after the third anniversary of the Effective Date and during the term of the Original Mazarakis Employment Agreement.

 

Under the Original Mazarakis Employment Agreement, Mr. Mazarakis was also to receive 19,000,000 Restricted Stock Units settled in subordinate voting shares of the Company (the “Performance-Vested RSUs”). The Performance-Vested RSUs were to become vested during the term of the Original Mazarakis Employment Agreement as follows: 1/3 of the Performance-Vested RSUs were to become vested when the 30-day VWAP of the Company shares exceeded US$0.85; an additional 1/3 were to become vested when the 30-day VWAP exceeded US$1.05; and the final 1/3 were to become vested when the 30-day VWAP exceeded US$1.25. Pursuant to Mazarakis Amendment No. 1, Mr. Mazarakis will now receive 19,000,000 Performance-Vested RSUs that vest as follows: 1/3 of the Performance-Vested RSUs shall become vested when the 6 month trailing, annualized, adjusted EBITDA (“AEBITDA”) exceeds $150,000,000 and the net leverage of the Company is below 2.2x; an additional 1/3 shall become vested when AEBITDA exceeds $165,000,000 and the net leverage of the Company is below 2.2x; and the final 1/3 shall become vested when AEBITDA exceeds $205,000,000 and the net leverage of the Company is below 2.2x.

 

Under the Original Mazarakis Employment Agreement, Mr. Mazarakis was entitled to certain bonus payments, subject to certain conditions, in the event of (i) the refinancing of any outstanding debt of the Company not less than $80,000,000 at an effective interest rate of not more than 9.75% with the bonus amount equal to 1% of the amount refinanced, (ii) the acquisition or merger with any entity where the total enterprise value of such other entity is $100,000,000 or greater, (iii) a Change of Control transaction, and (iv) the consummation of a transaction raising additional capital at a price per share greater than US$1.50.

 

Pursuant to Mazarakis Amendment No. 1, Mr. Mazarakis is now entitled to the bonus payments, subject to certain conditions, in the event of (i) the refinancing, without the use of an investment banker, of any outstanding debt of the Company not less than $60,000,000 at an effective rate of not more than 9.75% with the bonus amount equal to 0.8% of the amount refinanced; (ii) the acquisition or merger with an entity where the acquisition multiple is less than or equal to five times the total enterprise value of such other entity; (iii) a Change of Control transaction where the consideration per share (adjusted for stock splits and dividends) exceeds $1.15 per share; and (iv) the consummation of a transaction raising additional capital at a price per share greater than US$1.50.

 

 

 

 

Macdonald Amendment to Employment Agreement

 

Under Mr. Macdonald’s employment agreement dated December 17, 2024 (the “Original Macdonald Employment Agreement”), Mr. Macdonald was to be issued 9,5000,000 Restricted Stock Units settled in subordinate voting shares of the Company (the “Time-Vested RSUs”). The Time-Vested RSUs were to become 50% vested upon the first anniversary of the Effective Date (as defined under the Original Macdonald Employment Agreement) and the balance was to vest at the rate of 12.5% every three months thereafter until fully vested provided that Mr. Macdonald remained employed by the Company or an affiliate as of each applicable vesting date. Pursuant to Amendment No. 1 to the Original Macdonald Employment Agreement dated March 6, 2025 (“Macdonald Amendment No. 1”), Mr. Macdonald will now receive 9,5000,000 Time-Vested RSUs that will become 30% vested upon the first anniversary of the Effective Date. An additional 35% shall become vested when the 30-day weighted average price (“VWAP”) of the Company shares exceeds $0.85 (adjusted for dividends and stock splits) at any time on or after the second anniversary of the effective date of the agreement and during the term of the agreement. Any unvested shares shall become vested when the VWAP exceeds $1.05 (adjusted for dividends and stock splits) at any time on or after the third anniversary of the effective date and during the term of the agreement.

 

Under the Original Macdonald Employment Agreement, Mr. Macdonald was also to receive 9,500,000 Restricted Stock Units settled in subordinate voting shares of the Company (the “Performance-Vested RSUs”). The Performance-Vested RSUs were to become vested during the term of the agreement as follows: 1/3 of the Performance-Vested RSUs were to become vested when the 30-day VWAP of the Company shares exceeded US$0.85; an additional 1/3 shall were to become vested when the 30-day VWAP exceeded US$1.05; and the final 1/3 were to become vested when the 30-day VWAP exceeded US$1.25. Pursuant to Macdonald Amendment No. 1, Mr. Macdonald will now receive 9,500,000 Performance-Vested RSUs that vest as follows: 1/3 of the Performance-Vested RSUs shall become vested when the 6 month trailing, annualized, adjusted EBITDA (“AEBITDA”) exceeds $150,000,000 and the net leverage of the Company is below 2.2x; an additional 1/3 shall become vested when AEBITDA exceeds $165,000,000 and the net leverage of the Company is below 2.2x; and the final 1/3 shall become vested when AEBITDA exceeds $205,000,000 and the net leverage of the Company is below 2.2x.

 

Under the Original Macdonald Employment Agreement, Mr. Macdonald was entitled to certain bonus payments, subject to certain conditions, in the event of (i) the refinancing of any outstanding debt of the Company not less than $80,000,000 at an effective interest rate of not more than 9.75% with the bonus amount equal to 1.0% of the amount refinanced, (ii) the acquisition or merger with any entity where the total enterprise value of such other entity is $100,000,000 or greater, (iii) a Change of Control transaction, and (iv) the consummation of a transaction raising additional capital at a price per share greater than US$1.50.

 

Pursuant to Macdonald Amendment No. 1, Mr. Macdonald is now entitled to the bonus payments, subject to certain conditions, in the event of (i) the refinancing, without the use of an investment banker, of any outstanding debt of the Company not less than $60,000,000 at an effective rate of not more than 9.75% with the bonus amount equal to 0.4% of the amount refinanced; (ii) the acquisition or merger with an entity where the acquisition multiple is less than or equal to five times the total enterprise value of such other entity; (iii) a Change of Control transaction where the consideration per share (adjusted for stock splits and dividends) exceeds $1.15 per share; and (iv) the consummation of a transaction raising additional capital at a price per share greater than US$1.50.

 

This summary of the Mazarakis Amendment No. 1 and the Macdonald Amendment No. 1 are qualified in their entirety by reference to the full text of Mazarakis Amendment No. 1 and the Macdonald Amendment No. 1, which are attached hereto as Exhibits 10.1 and 10.2, respectively, and are incorporated herein by reference.

 

Item 9.01.Financial Statements and Exhibits

 

(d) Exhibits.

 

Exhibit No.   Description
10.1   First Amendment to Employment Agreement, dated March 6, 2025, by and between Vireo Growth Inc. and John Mazarakis
10.2   First Amendment to Employment Agreement, dated March 6, 2025, by and between Vireo Growth Inc. and Tyson Macdonald
104   Cover Page Interactive Data File (embedded within Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

VIREO GROWTH INC.

(Registrant)

   
  By: /s/ Tyson Macdonald
    Tyson Macdonald
    Chief Financial Officer

 

Date: March 9, 2025

 

 

 

 

Exhibit 10.1

 

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT

 

This First Amendment to Employment Agreement (“Amendment”) is made effective as of March 6, 2025 (“Amendment Effective Date”) by and between Vireo Growth Inc., a Canadian corporation (the “Company”), and John Mazarakis, an individual residing in the State of Florida (“Employee”) (collectively “Parties” or individually “Party”).

 

RECITALS

 

WHEREAS, the Company and Employee entered into an Employment Agreement (the “Original Agreement”) dated December 17, 2024;

 

WHEREAS, the Parties wish to modify the terms and conditions of certain incentive compensation arrangements otherwise set forth in the Original Agreement;

 

WHEREAS, the Parties wish to modify the terms and conditions of certain separation obligations otherwise set forth in the Original Agreement; and

 

WHEREAS, the Parties wish to amend the Original Agreement as set forth in this Amendment.

 

NOW, THEREFORE, in consideration of the mutual covenants and conditions contained herein, the receipt and sufficiency of which are hereby acknowledged, the Company and Employee, intending legally to be bound, hereby agree as follows:

 

AGREEMENT

 

1.            Equity and Incentive Compensation. Sections 4.2(b) through 4.2(f) of the Original Agreement are hereby deleted and the following substituted therefor:

 

(b)          Restricted Stock Units. The Company shall issue the Employee the following awards on the terms and conditions set forth below within thirty (30) days of the Amendment Effective Date following the receipt of approval by the Board and the receipt of shareholder approval:

 

i.            Time-Vested Awards. The Company shall issue to the Employee 19,000,000 Restricted Stock Units settled in Subordinate Voting Shares of the Company (or equivalent common shares should Subordinate Voting Shares cease to be available for issuance) (the “Time-Vested RSU’s”). The Time-Vested RSU’s shall become 30% vested upon the first anniversary of the Effective Date. An additional 35% shall become vested when the 30-day weighted average price (“VWAP”) of the Company shares exceeds $0.85 (adjusted for dividends and stock splits) at any time on or after the second anniversary of the Effective Date and during the Term. Any unvested shares shall become vested when the VWAP exceeds $1.05 (adjusted for dividends and stock splits) at any time on or after the third anniversary of the Effective Date and during the Term. Vesting will accelerate and the Time-Vested RSU’s will be 100% vested in the event that the Employee is terminated by the Company for any reason other than for Cause, upon a resignation by the Employee for Good Reason, upon the Employee’s death or Disability or upon the consummation of a transaction constituting a Change in Control. The award of Time-Vested RSU’s may be subject to the terms of an award agreement reasonably acceptable to the Employee that otherwise conforms to the requirements of this Section.

 

 

 

 

ii.           Performance-Vested Awards. The Company shall issue to the Employee 19,000,000 Restricted Stock Units settled in Subordinate Voting Shares of the Company (or equivalent common shares should Subordinate Voting Shares cease to be available for issuance) (the “Performance-Vested RSU’s”). The Performance-Vested RSU’s shall become vested during the Term as follows: 1/3 of the Performance-Vested RSU’s shall become vested when the 6 month trailing, annualized, adjusted EBITDA (“AEBITDA”) exceeds $150,000,000 USD and the net leverage of the company is below 2.2x, an additional 1/3 shall become vested when AEBITDA exceeds $165,000,000 USD and the net leverage of the company is below 2.2x, and the final 1/3 shall become vested when AEBITDA exceeds $205,000,000 USD and the net leverage of the company is below 2.2x. Vesting will accelerate and the Performance-Vested RSU’s will become 100% vested in the event that the Employee is terminated by the Company for any reason other than for Cause, upon a resignation by the Employee for Good Reason, upon the Employee’s death or Disability or upon the consummation of a transaction constituting a Change in Control. The award of Performance-Vested RSU’s may be subject to the terms of an award agreement reasonably acceptable to the Employee that otherwise conforms to the requirements of this Section.

 

(c)            Debt Refinance Bonus. In the event that, during the Term, the Company refinances any outstanding debt, without the use of an outside investment banker, of not less than $60,000,000 USD, whether in one or more refinancings, at an effective interest rate of not more than 9.75%, the Employee shall be entitled to the payment of a cash bonus in an amount equal to 0.8% of the total amount refinanced by the Company (the “Debt Refinance Bonus”). Any Debt Refinance Bonus payable under this Section shall be paid in a single lump-sum payment within 30 days following the consummation of the transactions otherwise triggering the obligation to pay the Debt Refinance Bonus. For the avoidance of doubt, a refinancing of $60,000,000 in year 1, $40,000,000 in year 2, and $30,000,000 in year 2 or any year thereafter, for an aggregate of $130,000,000, will result in a bonus of 0.8% multiplied by $130,000,000 paid in three payments following the closing of each refinancing event as otherwise provided herein.

 

(d)            Transaction Bonus. In the event that, during the Term, the Company consummates the acquisition of any other entity, or merger with another entity, where the acquisition multiple is less than or equal to 5 times the total enterprise value of such other entity, the Employee shall be entitled to the payment of a bonus in an amount equal to 2/3 of the difference between 3.00% of the total equity value of such acquired entity and the transaction fees to an outside investment advisor associated with the equity value portion of such acquired entity (the “Transaction Bonus”). Any Transaction Bonus payable under this Section shall be paid 50% in Subordinate Voting Shares of the Company (or equivalent common shares should Subordinate Voting Shares cease to be available for issuance) and 50% in a single lump-sum cash payment within 30 days following the consummation of the transaction otherwise triggering the obligation to pay the Transaction Bonus.

 

(e)            Sale of the Company. In the event that, during the Term, the Company consummates a Change in Control transaction where the consideration per share, adjusted for stock splits and dividends, exceeds $1.15 USD, the Employee shall be entitled to the payment of a cash bonus in an amount equal to the 2.0% of the total equity value of the Company in such transaction (“Sale Bonus”). Any Sale Bonus payable under this Section shall be paid in a single lump-sum cash payment within 30 days following the consummation of the transaction otherwise triggering the obligation to pay the Sale Bonus.

 

2 

 

 

(f)             Capital Raise Bonus. In the event that, during the Term, the Company consummates a transaction raising additional capital at a price per share greater than $1.50 USD, the Employee shall be entitled to the payment of a cash bonus in an amount equal to 2/3 of the difference between 3.00% of the total amount of consideration received by the Company and the transaction fees paid to an outside investment advisor associated with such transaction (the “Capital Raise Bonus”). Any Capital Raise Bonus payable under this Section shall be paid in a single lump-sum payment within 30 days following the consummation of the transaction otherwise triggering the obligation to pay the Capital Raise Bonus.

 

2.            Definition of Cause. Sections 6.4 of the Original Agreement is hereby deleted and the following substituted therefor:

 

6.4.           Cause Defined. “Cause” hereunder means any of Employee’s: (i) willful failure to comply with any valid and legal directive of the Board, (ii) willful engagement in dishonesty, illegal conduct, or gross misconduct, which is, in each case, injurious to the Company or any of its affiliates; (iii) embezzlement, misappropriation, or intentional fraud, whether or not related to Employee’s employment with the Company; (iv) indictment, conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent); (v) commission or conviction of a crime which would disqualify Employee for registration or licensure by the applicable regulatory or licensing authority governing the Company’s or any of its subsidiary’s or affiliate’s participation in a State-regulated cannabis program; (vi) material breach of any material obligation under this Agreement or any other written agreement between Employee and the Company or any of its subsidiaries; or (vii) any material failure by Employee to comply with the Company’s written policies or rules, as they may be in effect from time to time, that were previously provided to Employee, if such failure causes material reputational or financial harm to the Company or any of its affiliates. For the avoidance of doubt, if any action or omission by Employee could be deemed a violation of any U.S. federal law relating to the cultivation, harvesting, production, distribution, sale or possession of cannabis, marijuana or related substances or products containing or relating to the foregoing, and such action or omission is not a violation of, and is done in compliance with, applicable U.S. state law, then such action or omission shall not be deemed a basis for Cause hereunder. Notwithstanding the foregoing, no termination shall be considered a termination for Cause unless the Company provides Employee written notice within thirty (30) days of the date upon which the Company first becomes aware of the circumstances purporting to give rise to Cause which notice sets forth the specific circumstances purporting to give rise to Cause and identifying with specificity the action needed to cure. Employee shall be provided a period of not less than thirty (30) days from the receipt of such notice to effect such cure to the reasonable satisfaction of the Company.

 

3.            General. All capitalized terms used but not defined in this Amendment shall have the meanings ascribed in the Original Agreement. All provisions of the Original Agreement not expressly modified by this Amendment are hereby ratified and confirmed.

 

3 

 

 

[Signature Page Follow]

 

4 

 

 

THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT was voluntarily and knowingly executed by the Parties effective as of the Amendment Effective Date first set forth above.

 

  VIREO GROWTH INC.
   
  /s/ Kyle Kingsley
  By: Kyle Kingsley
  Its: Chairman of the Board
   
  EMPLOYEE:
   
  /s/ John Mazarakis
  John Mazarakis

 

[Signature Page to Employment Agreement]

 

 

 

 

Exhibit 10.2

 

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT

 

This First Amendment to Employment Agreement (“Amendment”) is made effective as of March 6, 2025 (“Amendment Effective Date”) by and between Vireo Growth Inc., a Canadian corporation (the “Company”), and Tyson Macdonald, an individual residing in the State of Maryland (“Employee”) (collectively “Parties” or individually “Party”).

 

RECITALS

 

WHEREAS, the Company and Employee entered into an Employment Agreement (the “Original Agreement”) dated December 17, 2024;

 

WHEREAS, the Parties wish to modify the terms and conditions of certain incentive compensation arrangements otherwise set forth in the Original Agreement;

 

WHEREAS, the Parties wish to modify the terms and conditions of certain separation obligations otherwise set forth in the Original Agreement; and

 

WHEREAS, the Parties wish to amend the Original Agreement as set forth in this Amendment.

 

NOW, THEREFORE, in consideration of the mutual covenants and conditions contained herein, the receipt and sufficiency of which are hereby acknowledged, the Company and Employee, intending legally to be bound, hereby agree as follows:

 

AGREEMENT

 

1.            Equity and Incentive Compensation. Sections 4.2(b) through 4.2(f) of the Original Agreement are hereby deleted and the following substituted therefor:

 

(b)           Restricted Stock Units. The Company shall issue the Employee the following awards on the terms and conditions set forth below within thirty (30) days of the Amendment Effective Date following the receipt of approval by the Board and the receipt of shareholder approval:

 

i.            Time-Vested Awards. The Company shall issue to the Employee 9,500,000 Restricted Stock Units settled in Subordinate Voting Shares of the Company (or equivalent common shares should Subordinate Voting Shares cease to be available for issuance) (the “Time-Vested RSU’s”). The Time-Vested RSU’s shall become 30% vested upon the first anniversary of the Effective Date. An additional 35% shall become vested when the 30-day weighted average price (“VWAP”) of the Company shares exceeds $0.85 (adjusted for dividends and stock splits) at any time on or after the second anniversary of the Effective Date and during the Term. Any unvested shares shall become vested when the VWAP exceeds $1.05 (adjusted for dividends and stock splits) at any time on or after the third anniversary of the Effective Date and during the Term. Vesting will accelerate and the Time-Vested RSU’s will be 100% vested in the event that the Employee is terminated by the Company for any reason other than for Cause, upon a resignation by the Employee for Good Reason, upon the Employee’s death or Disability or upon the consummation of a transaction constituting a Change in Control. The award of Time-Vested RSU’s may be subject to the terms of an award agreement reasonably acceptable to the Employee that otherwise conforms to the requirements of this Section.

 

 

 

 

ii.           Performance-Vested Awards. The Company shall issue to the Employee 9,500,000 Restricted Stock Units settled in Subordinate Voting Shares of the Company (or equivalent common shares should Subordinate Voting Shares cease to be available for issuance) (the “Performance-Vested RSU’s”). The Performance-Vested RSU’s shall become vested during the Term as follows: 1/3 of the Performance-Vested RSU’s shall become vested when the 6 month trailing, annualized, adjusted EBITDA (“AEBITDA”) exceeds $150,000,000 USD and the net leverage of the company is below 2.2x, an additional 1/3 shall become vested when AEBITDA exceeds $165,000,000 USD and the net leverage of the company is below 2.2x, and the final 1/3 shall become vested when AEBITDA exceeds $205,000,000 USD and the net leverage of the company is below 2.2x. Vesting will accelerate and the Performance-Vested RSU’s will become 100% vested in the event that the Employee is terminated by the Company for any reason other than for Cause, upon a resignation by the Employee for Good Reason, upon the Employee’s death or Disability or upon the consummation of a transaction constituting a Change in Control. The award of Performance-Vested RSU’s may be subject to the terms of an award agreement reasonably acceptable to the Employee that otherwise conforms to the requirements of this Section.

 

(c)            Debt Refinance Bonus. In the event that, during the Term, the Company refinances any outstanding debt, without the use of an outside investment banker, of not less than $60,000,000 USD, whether in one or more refinancings, at an effective interest rate of not more than 9.75%, the Employee shall be entitled to the payment of a cash bonus in an amount equal to 0.4% of the total amount refinanced by the Company (the “Debt Refinance Bonus”). Any Debt Refinance Bonus payable under this Section shall be paid in a single lump-sum payment within 30 days following the consummation of the transactions otherwise triggering the obligation to pay the Debt Refinance Bonus. For the avoidance of doubt, a refinancing of $60,000,000 in year 1, $40,000,000 in year 2, and $30,000,000 in year 2 or any year thereafter, for an aggregate of $130,000,000, will result in a bonus of 0.4% multiplied by $130,000,000 paid in three payments following the closing of each refinancing event as otherwise provided herein.

 

(d)           Transaction Bonus. In the event that, during the Term, the Company consummates the acquisition of any other entity, or merger with another entity, where the acquisition multiple is less than or equal to 5 times the total enterprise value of such other entity, the Employee shall be entitled to the payment of a bonus in an amount equal to 1/3 of the difference between 3.00% of the total equity value of such acquired entity and the transaction fees to an outside investment advisor associated with the equity value portion of such acquired entity (the “Transaction Bonus”). Any Transaction Bonus payable under this Section shall be paid 50% in Subordinate Voting Shares of the Company (or equivalent common shares should Subordinate Voting Shares cease to be available for issuance) and 50% in a single lump-sum cash payment within 30 days following the consummation of the transaction otherwise triggering the obligation to pay the Transaction Bonus.

 

(e)            Sale of the Company. In the event that, during the Term, the Company consummates a Change in Control transaction where the consideration per share, adjusted for stock splits and dividends, exceeds $1.15 USD, the Employee shall be entitled to the payment of a cash bonus in an amount equal to the 1.0% of the total equity value of the Company in such transaction (“Sale Bonus”). Any Sale Bonus payable under this Section shall be paid in a single lump-sum cash payment within 30 days following the consummation of the transaction otherwise triggering the obligation to pay the Sale Bonus.

 

2 

 

 

(f)            Capital Raise Bonus. In the event that, during the Term, the Company consummates a transaction raising additional capital at a price per share greater than $1.50 USD, the Employee shall be entitled to the payment of a cash bonus in an amount equal to 1/3 of the difference between 3.00% of the total amount of consideration received by the Company and the transaction fees paid to an outside investment advisor associated with such transaction (the “Capital Raise Bonus”). Any Capital Raise Bonus payable under this Section shall be paid in a single lump-sum payment within 30 days following the consummation of the transaction otherwise triggering the obligation to pay the Capital Raise Bonus.

 

2.            Definition of Cause. Sections 6.4 of the Original Agreement is hereby deleted and the following substituted therefor:

 

6.4.          Cause Defined. “Cause” hereunder means any of Employee’s (i) willful failure to comply with any valid and legal directive of the Board, (ii) willful engagement in dishonesty, illegal conduct, or gross misconduct, which is, in each case, injurious to the Company or any of its affiliates; (iii) embezzlement, misappropriation, or intentional fraud, whether or not related to Employee’s employment with the Company; (iv) indictment, conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent); (v) commission or conviction of a crime which would disqualify Employee for registration or licensure by the applicable regulatory or licensing authority governing the Company’s or any of its subsidiary’s or affiliate’s participation in a State-regulated cannabis program; (vi) material breach of any material obligation under this Agreement or any other written agreement between Employee and the Company or any of its subsidiaries; or (vii) any material failure by Employee to comply with the Company’s written policies or rules, as they may be in effect from time to time, that were previously provided to Employee, if such failure causes material reputational or financial harm to the Company or any of its affiliates. For the avoidance of doubt, if any action or omission by Employee could be deemed a violation of any U.S. federal law relating to the cultivation, harvesting, production, distribution, sale or possession of cannabis, marijuana or related substances or products containing or relating to the foregoing, and such action or omission is not a violation of, and is done in compliance with, applicable U.S. state law, then such action or omission shall not be deemed a basis for Cause hereunder. Notwithstanding the foregoing, no termination shall be considered a termination for Cause unless the Company provides Employee written notice within thirty (30) days of the date upon which the Company first becomes aware of the circumstances purporting to give rise to Cause which notice sets forth the specific circumstances purporting to give rise to Cause and identifying with specificity the action needed to cure. Employee shall be provided a period of not less than thirty (30) days from the receipt of such notice to effect such cure to the reasonable satisfaction of the Company.

 

3.            General. All capitalized terms used but not defined in this Amendment shall have the meanings ascribed in the Original Agreement. All provisions of the Original Agreement not expressly modified by this Amendment are hereby ratified and confirmed.

 

3 

 

 

[Signature page follows]

 

4 

 

 

THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT was voluntarily and knowingly executed by the Parties effective as of the Amendment Effective Date first set forth above.

 

  VIREO GROWTH INC.
   
  /s/ Kyle Kingsley
  By: Kyle Kingsley
  Its: Chairman of the Board
   
  EMPLOYEE:
   
  /s/ Tyson Macdonald
  Tyson Macdonald

 

[Signature Page to Employment Agreement]